Cefrasyn 500 mg is a capsule containing cephradine, a first generation cephalosporin antibiotic made by MST Pharma and Healthcare Ltd. It is a prescription medicine used to treat certain bacterial infections.
There are 228 brands of Cephradine listed in Bangladesh. 53 of them have a lower unit price than Cefrasyn. The lowest listed price is Belocef 500 mg Capsule at ৳ 1 per unit.
What is Cefrasyn 500 mg Capsule?
Cefrasyn 500 mg is an oral antibiotic capsule. Its active ingredient is cephradine, which belongs to the first generation cephalosporin group. Cephradine works by interfering with the building of the bacterial cell wall, which leads to the breakdown of the bacteria. It is active against a range of Gram-positive and Gram-negative bacteria. Because antibiotics act only on bacteria, your doctor will decide whether it suits your infection. Cefrasyn is available only on the prescription of a registered physician, and the dose and course are set by your doctor.
Uses of Cefrasyn
Cefrasyn is used to treat infections caused by bacteria that are sensitive to cephradine. These include upper respiratory tract infections such as sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and lower respiratory tract infections such as acute and chronic bronchitis and lobar pneumonia. Doctors may also prescribe it for other infections depending on the assessment. Your doctor will confirm whether it is suitable for your condition.
How to use Cefrasyn
Cefrasyn 500 mg capsules are taken by mouth. Your doctor decides the dose, how often to take it and how long the course should last, and you should follow those instructions exactly. Do not change the dose or stop early on your own, even if you start to feel better, because finishing the course as prescribed helps clear the infection. If you miss a dose, ask your doctor or pharmacist what to do. Ask them also about any food instructions.
Side effects of Cefrasyn
Side effects are mainly limited to the stomach and bowel, and sometimes to hypersensitivity reactions. These reactions are more likely in people who have shown hypersensitivity before, or who have a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare effects include glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis and candida overgrowth. Skin and hypersensitivity reactions can include urticaria, skin rashes, joint pains and oedema. Tell your doctor if any effect troubles you.
Safety and precautions
Do not use Cefrasyn if you have a known or suspected allergy to cephalosporins. It should be given with care to people who are sensitive to penicillins, because of the risk of cross-sensitivity between beta-lactam antibiotics. Prolonged use may lead to superinfection with resistant organisms. The medicine may cause dizziness, so take care with driving or operating hazardous machinery. Safety in pregnancy has not been established, and it is excreted in breast milk, so pregnant or breastfeeding women should speak to a doctor before use. People with kidney problems or a history of allergy should ask a doctor first.
Frequently asked questions
What is Cefrasyn used for, and what kind of medicine is it?
Cefrasyn 500 mg is a capsule antibiotic of the first generation cephalosporin group, with cephradine as its active ingredient. It is used for certain bacterial infections of the respiratory tract, such as sinusitis, tonsillitis, otitis media, bronchitis and lobar pneumonia. Your doctor will decide if it is right for your infection.
Is Cefrasyn safe in pregnancy or while breastfeeding?
Safety in pregnancy has not been established, and cephradine is excreted in breast milk, so it should be used with caution in breastfeeding mothers. If you are pregnant, think you may be pregnant, or are breastfeeding, speak to your doctor before taking it. Do not start or stop it on your own.
Which medicines may interact with Cefrasyn?
Using nephrotoxic drugs such as aminoglycosides together with cephradine may raise the risk of kidney damage. Diuretics such as frusemide and ethacrynic acid, and probenecid, may increase the possibility of renal toxicity. Tell your doctor or pharmacist about all medicines you take, including ones bought without prescription.
Cephradine is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include-
Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also
... Read more
Cephradine is indicated for the treatment of infections caused by sensitive Gram-positive and Gram-negative bacteria. These include-
Undesirable Upper respiratory tract infections: sinusitis, pharyngitis, tonsillitis, laryngo-tracheo bronchitis and otitis media, and also
Lower respiratory tract infections: bronchitis (acute and chronic), lobar pneumonia and bronchopneumonia.
Urinary tract infections: cystitis, urethritis and pyelonephritis.
Skin and soft tissue infections: abscess, cellulitis, furunculosis and impetigo.
The following microorganisms are susceptible, in vitro to Cephradine:
Gram-positive: Staphylococci (both penicillin sensitive and resistant strains and penicillinase-producing species), Streptococci, Streptococci pyogenes (beta haemolytic), Streptococcus pneumonia.
Gram-negative: Escherichia coli, Klebsiella spp, Proteus mirabilis, Haemophilus influenza, Shigella spp, Salmonella spp (including Salmonella typhi), Neisseria spp Many strains of E.coli and Staphylococcus aureus that produce the enzyme penicillinase and thus are ampicillin resistant, are susceptible to Cephradine which is unaffected by this enzyme.
Pharmacology
Cephradine is a semisynthetic broad spectrum bactericidal antibiotic, it is active against infections caused by both gram-positive and gram-negative microorganisms. Both penicillinase producing and nonproducing staphylococci are sensitive to Cephradine. The main site of action of Cephradine is the cell wall of bacteria. Cell wall of sensitive organism contains peptidoglycan. Cephradine inhibits cross-linking process and as a result cell wall with many pores are formed, thus lysis of bacteria occur due to external osmotic pressure.
Dosage & Administration
For oral administration- Adults:
Urinary tract infections: 500mg four times daily or 1g twice daily. Infections which are severe or chronic may necessitate the administration of higher doses. Where complications arise including prostatitis and epididymitis continued intensive treatment is required.
Respiratory tract infections: 250 to 500mg four times daily or 500mg to 1g twice daily, dependent on the site and severity of the infection.
Skin and soft tissue infections: 250 to 500mg four times daily or 500mg to 1g twice daily, again dependent on the site and severity of the infection.
Children:
Total daily dose of 25 to 50mg/kg given in two or four equally divided doses.
Otitis media: Total daily dose of 75 to 100mg/kg given in divided doses 6 to 12 hourly.
Maximum daily dosage: 4 gm
Elderly: The normal adult dose is appropriate. Patients with impaired renal or hepatic function should be monitored during treatment.
For injectable administration-
Adult: The usual dose is 2-4 gm daily in four equally divided doses up to 8 gm daily. For prophylaxis a single preoperative dose of 1-2 gm intramuscularly or intravenously is given.
Children: The dose is 50-100 mg/kg daily in four equally divided doses, up to 300 mg/kg daily in severe infection.
Interaction
The concomitant use of nephrotoxic drugs such as aminoglycosides with Cefradine may increase the risk of kidney damage. Diuretics (e.g. frusemide, ethacrynic acid) and probenecid enhanced the possibility of renal toxicity.
Contraindications
Cephradine should not be used in patients with known or suspected hypersensitivity to cephalosporins.
Side Effects
Limited essentially to gastro-intestinal disturbances and on occasions to hypersensitivity phenomena. The latter are more likely to occur in individuals, who have previously demonstrated hypersensitivity and thos with a history of allergy, asthma, hay fever or urticaria. Skin reactions have occasionally been reported. Rare- Glossitis, heartburn, dizziness, tightness in the chest, nausea, vomiting, diarrhoea, abdominal pain, vaginitis, candida overgrowth. Skin and hypersensitivity reactions include urticaria, skin rashes, joint pains, oedema.
Blood and lymphatic system disorders- Unknown: blood disorders (including thrombocytopenia, leucopenia, agranulocytosis, aplastic anaemia and haemolytic anaemia)
Immune system disorders- Unknown: Fever, serum sickness like reactions, anaphylaxis
Renal and urinary disorders- Unknown: Reversible interstitial nephritis
Investigations- Unknown: Elevation of blood urea nitrogen, serum creatinine, alanine aminotransferase, aspartate aminotransferase, total bilirubin, alkaline phosphatase.
Pregnancy & Lactation
Although animal studies have not demonstrated any teratogenicity, safety in pregnancy has not been established. Cephradine is excreted in breast milk and should be used with caution in lactating mothers. Since the medicine may cause dizziness, patients should be cautioned about operating hazardous machinery, including automobiles.
Precautions & Warnings
Prolonged use of an anti-infective may result in the development of superinfection due to the emergence of resistant organisms.
Cephradine should be administered with care to patients hypersensitive to penicillins because of the risk of cross-sensitivity between beta-lactam antibiotics.
Cephalosporin antibiotics may cause a positive result in Coombs’ testing. When Coombs testing is performed on neonates whose mothers received cephalosporins prior to labour, it should be noted that a positive result may be due to the drug.
Cephradine may cause a false positive urine glucose result when Benedict’s or Fehling’s solutions or tablets such as Clinitest are used in the testing. This does not occur with enzyme-based tests (e.g. Clinistix, Diastix).
Dosage adjustment is necessary in renal impairment.
This product contains lactose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.
Overdose Effects
The symptoms of Sefrad overdose are non-specific and are generally nausea, vomiting, diarrhoea and gastric upsets. Treatment is mainly supportive although gastric lavage will be necessary if a large amount has been ingested.
Storage Conditions
Cephradine Suspension should be freshly prepared. Reconstituted Suspension should be used within 7 days if kept at room temperature or within 14 days, if kept in a refrigerator. Cephradine Injection solutions should be used within 2 hours when kept at room temperature. When stored at 5°C, solutions retain potency for 12 hours. Reconstituted solutions may vary in colour from light to straw yellow; however, this does not affect the potency. Do not use later than the date of expiry. Keep all medicines out of the reach of children. To be dispensed only on the prescription of a registered physician
Alternative brands of Cephradine
Other brands with the same generic name, cheapest first.